Suppr超能文献

胸部立体定向放射治疗后放射性肋骨骨折的剂量效应分析。

Dose-effect analysis of radiation induced rib fractures after thoracic SBRT.

作者信息

Stam Barbara, van der Bijl Erik, Peulen Heike, Rossi Maddalena M G, Belderbos José S A, Sonke Jan-Jakob

机构信息

Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Radiother Oncol. 2017 May;123(2):176-181. doi: 10.1016/j.radonc.2017.01.004. Epub 2017 Jan 19.

Abstract

BACKGROUND AND PURPOSE

To determine a dose-effect relation for radiation induced rib fractures after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC). Automatic rib delineation has enabled the analysis of a large patient group.

MATERIAL AND METHODS

Four-hundred and sixty-six patients with stage I/II NSCLC received SBRT with a median of 54Gy in 3 fractions. The optimal EQD2-corrected dose parameter to predict (a)symptomatic fractures was found using Cox regression. Three normal tissue complication probability (NTCP) models based on this optimal parameter were constructed: (1) at a median follow up (FU) of 26months, (2) for all data, with time to toxicity taken into account and (3) at a FU of 26months, excluding low dose ribs.

RESULTS

The median time to fracture was 22 (range 5-51) months. Maximum rib dose best predicted fractures. The TD (dose with 50% complication) of the second NTCP model was 375Gy. The TD was significantly higher for the other models indicating an under-estimation of the dose effect at the median follow-up time and/or when excluding low dose ribs.

CONCLUSIONS

The risk of symptomatic rib fractures after SBRT was significantly correlated to dose, and was <5% at 26months when D<225Gy.

摘要

背景与目的

确定早期非小细胞肺癌(NSCLC)立体定向体部放疗(SBRT)后放射性肋骨骨折的剂量效应关系。自动肋骨轮廓勾画技术使得对大量患者群体进行分析成为可能。

材料与方法

466例I/II期NSCLC患者接受了SBRT,中位剂量为54Gy,分3次给予。使用Cox回归分析确定预测(有)症状性骨折的最佳等效剂量2(EQD2)校正剂量参数。基于该最佳参数构建了3种正常组织并发症概率(NTCP)模型:(1)中位随访(FU)26个月时;(2)纳入所有数据,并考虑毒性发生时间;(3)随访26个月时,排除低剂量肋骨。

结果

骨折的中位时间为22(5-51)个月。肋骨最大剂量最能预测骨折情况。第二个NTCP模型的50%并发症剂量(TD)为375Gy。其他模型的TD显著更高,表明在中位随访时间和/或排除低剂量肋骨时,剂量效应被低估。

结论

SBRT后有症状性肋骨骨折的风险与剂量显著相关,当D<225Gy时,26个月时该风险<5%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验